Skip to main content
Fig. 6 | Journal of Inflammation

Fig. 6

From: Intestinally-restricted Janus Kinase inhibition: a potential approach to maximize the therapeutic index in inflammatory bowel disease therapy

Fig. 6

Effect of tofacitinib on intrarectally infused IFNγ-induced pSTAT1 production in mouse colon. Data (mean ± SEM, n = 4–11) are expressed with respect to (a) dose and (b) concentration. (c) Concentration/response curve to tofacitinib in the mouse isolated colon with respect to IFNγ-induced pSTAT1 production (mean ± SEM, n = 3–18)

Back to article page